Latest news with #pan-European
Saba Yemen
2 days ago
- Business
- Saba Yemen
Stocks European start trading steady
Brussels - (Saba): European stock indices started trading on Wednesday with no change. The pan-European STOXX 600 index stabilized at 552.56 points, pausing temporarily after two consecutive sessions of gains. The German DAX index rose 0.1 percent, after reaching a record closing high on Tuesday, and the French CAC index rose 0.2 percent. Whatsapp Telegram Email Print
Yahoo
2 days ago
- Business
- Yahoo
European Value Stocks Priced Below Estimated Intrinsic Worth
The European stock market has recently faced downward pressure, with the pan-European STOXX Europe 600 Index dropping by 0.75% amid heightened trade tensions following proposed tariffs from the U.S. administration. In this challenging environment, identifying stocks that are priced below their intrinsic value can offer investors potential opportunities to capitalize on market inefficiencies and position themselves for long-term gains. Name Current Price Fair Value (Est) Discount (Est) Micro Systemation (OM:MSAB B) SEK49.60 SEK96.51 48.6% Laboratorios Farmaceuticos Rovi (BME:ROVI) €52.35 €104.47 49.9% Alfio Bardolla Training Group (BIT:ABTG) €1.88 €3.70 49.2% adidas (XTRA:ADS) €220.50 €433.62 49.1% Clemondo Group (OM:CLEM) SEK10.80 SEK21.24 49.2% Absolent Air Care Group (OM:ABSO) SEK215.00 SEK416.92 48.4% Lectra (ENXTPA:LSS) €24.75 €47.27 47.6% dormakaba Holding (SWX:DOKA) CHF733.00 CHF1399.64 47.6% Claranova (ENXTPA:CLA) €2.805 €5.45 48.5% Northern Data (DB:NB2) €25.02 €49.53 49.5% Click here to see the full list of 182 stocks from our Undervalued European Stocks Based On Cash Flows screener. Let's dive into some prime choices out of the screener. Overview: A.L.A. società per azioni is a supply chain solutions provider serving the aerospace and defense, rail, and high-tech sectors with a market cap of €314.24 million. Operations: The company's revenue is primarily derived from its Distribution segment at €140.29 million, followed by Service Providers at €120.54 million, Production at €23.15 million, and On Site Assembly at €5.91 million. Estimated Discount To Fair Value: 26.7% A.L.A. società per azioni is trading at €34.8, significantly below its estimated fair value of €47.49, reflecting a potential undervaluation based on cash flows. Despite a high level of non-cash earnings and debt not well covered by operating cash flow, the company's earnings grew 71.7% last year and are forecast to grow 22.3% annually, outpacing the Italian market's growth rate of 7.4%. Our earnings growth report unveils the potential for significant increases in A.L.A. società per azioni's future results. Click here and access our complete balance sheet health report to understand the dynamics of A.L.A. società per azioni. Overview: Datalogic S.p.A. is a company that produces and distributes automatic data capture and process automation products across various regions including Italy, the Americas, the Asia Pacific, Europe, the Middle East, and Africa with a market cap of €248.65 million. Operations: Datalogic's revenue is primarily derived from two segments: Data Capture, contributing €338.70 million, and Industrial Automation, generating €156.49 million. Estimated Discount To Fair Value: 15% Datalogic is trading at €4.64, 15% below its estimated fair value of €5.45, indicating potential undervaluation based on cash flows. Despite a recent quarterly net loss of €5.86 million and declining profit margins, earnings are projected to grow significantly at 57.72% annually over the next three years, outpacing both revenue growth and the Italian market's earnings growth rate of 7.4%. However, its dividend yield of 2.59% is not well covered by earnings or free cash flows. According our earnings growth report, there's an indication that Datalogic might be ready to expand. Unlock comprehensive insights into our analysis of Datalogic stock in this financial health report. Overview: Cicor Technologies Ltd., along with its subsidiaries, develops and manufactures electronic components, devices, and systems globally, with a market cap of CHF548.70 million. Operations: The company's revenue segments include the Advanced Substrates (AS) Division, generating CHF45.31 million, and the Electronic Manufacturing Services (EMS) Division, contributing CHF438.01 million. Estimated Discount To Fair Value: 12.2% Cicor Technologies, trading at CHF126, is slightly undervalued based on discounted cash flow analysis with an estimated fair value of CHF143.47. Despite recent shareholder dilution and high share price volatility, earnings are expected to grow significantly at 21.48% annually over the next three years, surpassing Swiss market averages. Recent strategic moves include a supply agreement with Mercury Mission Systems to enhance its European aerospace and defense presence, potentially boosting future revenue streams. Insights from our recent growth report point to a promising forecast for Cicor Technologies' business outlook. Take a closer look at Cicor Technologies' balance sheet health here in our report. Click through to start exploring the rest of the 179 Undervalued European Stocks Based On Cash Flows now. Shareholder in one or more of these companies? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments. Streamline your investment strategy with Simply Wall St's app for free and benefit from extensive research on stocks across all corners of the world. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include BIT:ALA BIT:DAL and SWX:CICN. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 days ago
- Business
- Yahoo
Exploring Undiscovered Gems in Europe This May 2025
As Europe grapples with the impact of proposed U.S. tariffs, the pan-European STOXX Europe 600 Index recently snapped a five-week streak of gains, reflecting broader market uncertainties. In this climate, identifying hidden opportunities in small-cap stocks can be particularly rewarding for investors seeking growth potential amidst economic fluctuations and shifting trade policies. Name Debt To Equity Revenue Growth Earnings Growth Health Rating AB Traction NA 5.39% 5.24% ★★★★★★ Linc NA 101.28% 29.81% ★★★★★★ La Forestière Equatoriale NA -65.30% 37.55% ★★★★★★ ABG Sundal Collier Holding 8.55% -4.14% -12.38% ★★★★★☆ Flügger group 20.98% 3.24% -29.82% ★★★★★☆ Decora 18.47% 11.59% 10.86% ★★★★★☆ Alantra Partners 3.79% -3.99% -23.83% ★★★★★☆ Inversiones Doalca SOCIMI 15.57% 6.53% 7.16% ★★★★☆☆ Castellana Properties Socimi 53.49% 6.64% 21.96% ★★★★☆☆ Eurofins-Cerep 0.46% 6.80% 6.93% ★★★★☆☆ Click here to see the full list of 325 stocks from our European Undiscovered Gems With Strong Fundamentals screener. We're going to check out a few of the best picks from our screener tool. Simply Wall St Value Rating: ★★★★★★ Overview: Rosetti Marino SpA, along with its subsidiaries, operates in the energy, energy transition, and shipbuilding sectors across Italy, the European Union, and globally with a market capitalization of €235.60 million. Operations: Rosetti Marino generates revenue primarily from its Oil & Gas Business Unit (€403.62 million) and Renewables and Carbon segment (€172.70 million), with smaller contributions from various services (€0.60 million) and shipbuilding (€2.96 million). The company's financial performance is significantly driven by the oil and gas sector, which constitutes a substantial portion of its revenue mix. Rosetti Marino, a standout in the energy services sector, has shown impressive growth with earnings surging 323% over the past year, significantly outpacing the industry average of 15.4%. The company's debt to equity ratio improved from 36.2% to 34.6% over five years, reflecting prudent financial management. Trading at a price-to-earnings ratio of just 7.9x compared to the Italian market's 15.9x, it offers good value for investors seeking opportunities in smaller companies. Recent results show net income jumping from €7 million to €29.8 million annually, further highlighting its robust performance and potential for continued success in its field. Take a closer look at Rosetti Marino's potential here in our health report. Learn about Rosetti Marino's historical performance. Simply Wall St Value Rating: ★★★★☆☆ Overview: SpareBank 1 Ringerike Hadeland is a financial institution offering a range of banking products and services to private and corporate customers in Norway, with a market cap of NOK6.16 billion. Operations: The bank generates revenue primarily through interest income, fees, and commissions from its various banking products and services. It focuses on managing costs efficiently to support its financial performance. SpareBank 1 Ringerike Hadeland, with total assets of NOK31.7 billion and equity of NOK4.9 billion, is a compact player in the banking sector. Its financial health seems robust with 80% of its liabilities funded through customer deposits, minimizing risk compared to external borrowing. The bank's earnings surged by 44.9% last year, outpacing the industry's modest 6.4% growth rate and showcasing high-quality past earnings despite an anticipated annual decline of 4.7% over the next three years. Trading at a notable discount to its estimated fair value by 32%, it remains free cash flow positive, indicating solid operational efficiency amidst competitive pressures. Navigate through the intricacies of SpareBank 1 Ringerike Hadeland with our comprehensive health report here. Explore historical data to track SpareBank 1 Ringerike Hadeland's performance over time in our Past section. Simply Wall St Value Rating: ★★★★☆☆ Overview: Dynavox Group AB (publ) focuses on developing and selling assistive technology products for individuals with communication impairments, with a market capitalization of approximately SEK10.55 billion. Operations: Dynavox Group generates revenue primarily from its computer hardware segment, amounting to SEK2.13 billion. The company's market capitalization stands at approximately SEK10.55 billion. Dynavox Group, a promising player in the tech industry, is making strategic moves with its acquisition of Cenomy in France and investments in ERP systems. This expansion aims to bolster global presence and operational efficiency. The company reported first-quarter sales of SEK 581 million, up from SEK 428 million last year, with net income rising to SEK 24 million. Despite a high net debt-to-equity ratio of 123.7%, interest payments are well-covered by EBIT at 5.8 times coverage. Recent share repurchase initiatives reflect confidence in future growth prospects despite potential risks like healthcare reimbursement complexities and currency fluctuations impacting financial performance. Dynavox Group's strategic acquisition of Cenomy boosts its market presence in France. Click here to explore the full narrative on Dynavox Group's growth strategy and market expansion. Navigate through the entire inventory of 325 European Undiscovered Gems With Strong Fundamentals here. Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive. Enhance your investing ability with the Simply Wall St app and enjoy free access to essential market intelligence spanning every continent. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include BIT:YRM OB:RING and OM:DYVOX. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 days ago
- Business
- Yahoo
High Growth Tech Stocks In Europe May 2025
The European market has recently faced challenges, with the pan-European STOXX Europe 600 Index ending a streak of gains due to proposed U.S. tariffs on EU goods, while economic growth forecasts have been revised downward amid rising uncertainties. In this environment, identifying high-growth tech stocks involves looking for companies that can navigate trade tensions and leverage innovation to maintain robust performance despite broader market pressures. Name Revenue Growth Earnings Growth Growth Rating KebNi 21.51% 66.96% ★★★★★★ Intellego Technologies 31.55% 51.31% ★★★★★★ Archos 21.07% 36.58% ★★★★★★ Yubico 20.18% 30.36% ★★★★★★ Pharma Mar 26.03% 43.09% ★★★★★★ Bonesupport Holding 29.14% 56.14% ★★★★★★ CD Projekt 33.21% 37.35% ★★★★★★ XTPL 86.66% 143.68% ★★★★★★ Skolon 31.51% 99.52% ★★★★★★ Elliptic Laboratories 36.33% 78.99% ★★★★★★ Click here to see the full list of 226 stocks from our European High Growth Tech and AI Stocks screener. Here's a peek at a few of the choices from the screener. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Lumibird SA is a company that specializes in designing, manufacturing, and selling lasers for scientific, industrial, and medical applications globally, with a market capitalization of €330.14 million. Operations: The company generates revenue from two main segments: Medical (€107.75 million) and Photonic (€99.37 million). Lumibird, a player in the European tech scene, has demonstrated a mixed financial trajectory recently. Despite a challenging year with earnings declining by 20.1%, forecasts are optimistic with an expected annual earnings growth of 37.3%. This growth rate notably surpasses the French market's average of 12.1%. Additionally, Lumibird's revenue is also set to outpace the local market, projecting an increase of 7.1% per year compared to the broader market's 5%. However, it's crucial to note that past financial results have been impacted by a significant one-off loss of €3.4 million as of December 2024. With such dynamics at play, Lumibird presents both opportunities and risks within the high-growth tech sector in Europe. Click here and access our complete health analysis report to understand the dynamics of Lumibird. Examine Lumibird's past performance report to understand how it has performed in the past. Simply Wall St Growth Rating: ★★★★★☆ Overview: BioInvent International AB (publ) is a clinical-stage company focused on discovering and developing novel immuno-modulatory antibodies for cancer treatment, with a market cap of approximately SEK2.43 billion. Operations: BioInvent focuses on developing antibody-based drugs, generating revenue of SEK60.80 million from this segment. The company operates in Sweden, Europe, the United States, and other international markets. BioInvent International, a Swedish biotech firm, is making notable strides in the high-growth tech sector in Europe with an impressive forecasted annual revenue growth rate of 76.6%, significantly outpacing the Swedish market's average of 4.2%. Despite being currently unprofitable, the company is expected to reach profitability within three years, reflecting an anticipated robust annual profit growth. Recent developments include promising Phase 2a study results of BI-1808 for Cutaneous T-cell Lymphoma presented at the EHA congress and FDA's Fast Track Designation for this innovative treatment, highlighting BioInvent's potential to transform therapeutic approaches in oncology through its focused R&D efforts which continue to attract significant investment and interest within the biotechnological landscape. Get an in-depth perspective on BioInvent International's performance by reading our health report here. Assess BioInvent International's past performance with our detailed historical performance reports. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Hanza AB (publ) is a company that offers manufacturing solutions, with a market capitalization of approximately SEK3.76 billion. Operations: The company generates revenue primarily from its Main Markets segment, which accounts for SEK2.92 billion, and Other Markets contributing SEK2.06 billion. The Business Development and Services segment adds SEK32 million to the total revenue. Hanza is distinguishing itself in the European tech sector with an annual revenue growth rate of 9.9%, outstripping the Swedish market average of 4.2%. Despite a challenging past year marked by a 38.1% earnings decline, forecasts suggest robust future earnings growth at an annual rate of 27.7%. The company's recent financials reveal a net income rise to SEK 40 million from SEK 34 million year-over-year, supported by sales increasing to SEK 1,326 million from SEK 1,253 million. These figures underscore Hanza's resilience and potential for sustained growth amidst market adversities. Unlock comprehensive insights into our analysis of Hanza stock in this health report. Explore historical data to track Hanza's performance over time in our Past section. Dive into all 226 of the European High Growth Tech and AI Stocks we have identified here. Already own these companies? Bring clarity to your investment decisions by linking up your portfolio with Simply Wall St, where you can monitor all the vital signs of your stocks effortlessly. Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ENXTPA:LBIRD OM:BINV and OM:HANZA. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 days ago
- Business
- Yahoo
European Value Stocks: 3 Companies Trading Below Estimated Worth
The European stock market recently faced a downturn, with the pan-European STOXX Europe 600 Index ending lower after five weeks of gains, influenced by new tariff threats from the U.S. and unexpected contractions in business activity. In this environment, investors might look for value opportunities in stocks trading below their estimated worth, as these can offer potential resilience and growth despite broader market challenges. Name Current Price Fair Value (Est) Discount (Est) Micro Systemation (OM:MSAB B) SEK49.60 SEK96.51 48.6% Laboratorios Farmaceuticos Rovi (BME:ROVI) €52.35 €104.47 49.9% Alfio Bardolla Training Group (BIT:ABTG) €1.88 €3.70 49.2% adidas (XTRA:ADS) €220.50 €433.62 49.1% Clemondo Group (OM:CLEM) SEK10.80 SEK21.24 49.2% Absolent Air Care Group (OM:ABSO) SEK215.00 SEK416.92 48.4% Lectra (ENXTPA:LSS) €24.75 €47.27 47.6% dormakaba Holding (SWX:DOKA) CHF733.00 CHF1399.64 47.6% Fodelia Oyj (HLSE:FODELIA) €7.00 €13.31 47.4% Claranova (ENXTPA:CLA) €2.805 €5.45 48.5% Click here to see the full list of 181 stocks from our Undervalued European Stocks Based On Cash Flows screener. Below we spotlight a couple of our favorites from our exclusive screener. Overview: REVO Insurance S.p.A. is an Italian insurance company with a market cap of €378.54 million. Operations: The company's revenue primarily comes from its Damage Management segment, which generated €317.62 million. Estimated Discount To Fair Value: 27.6% REVO Insurance is trading at a significant discount, approximately €14.96 compared to its estimated fair value of €20.65, suggesting undervaluation based on discounted cash flow analysis. The company reported a substantial net income increase to €18.58 million for 2024 and forecasts strong earnings growth of 24.3% annually over the next three years, outpacing the Italian market's average growth rate, despite having a forecasted low return on equity of 14.4%. Upon reviewing our latest growth report, REVO Insurance's projected financial performance appears quite optimistic. Dive into the specifics of REVO Insurance here with our thorough financial health report. Overview: BlueNord ASA is an oil and gas company engaged in the exploration, development, and production of hydrocarbon resources across Norway, Denmark, the Netherlands, and the United Kingdom with a market cap of NOK15.42 billion. Operations: The company's revenue from its oil and gas exploration and production activities amounts to $704.90 million. Estimated Discount To Fair Value: 31.1% BlueNord is trading at NOK582, significantly below its estimated fair value of NOK844.91, indicating potential undervaluation based on discounted cash flow analysis. Recent earnings show a turnaround with net income rising to US$18.6 million from a loss last year, and revenue reaching US$171.1 million for Q1 2025. Despite interest payments not well covered by earnings, production ramp-up at Tyra II supports future profitability expectations above market growth rates in Norway. The growth report we've compiled suggests that BlueNord's future prospects could be on the up. Delve into the full analysis health report here for a deeper understanding of BlueNord. Overview: PSI Software SE develops and integrates software solutions to optimize energy and materials flow for utilities and industry globally, with a market cap of €461.54 million. Operations: The company's revenue is primarily derived from Process Industries & Metals (€72.15 million), Logistics (€33.77 million), and Discrete Manufacturing (€31.70 million). Estimated Discount To Fair Value: 33.6% PSI Software is trading at €29.8, well below its estimated fair value of €44.87, highlighting potential undervaluation based on discounted cash flow analysis. The company reported a significant improvement in Q1 2025 earnings with sales rising to €67.9 million and net income turning positive at €0.271 million from a substantial loss last year. With expected revenue growth outpacing the German market and a strategic partnership with Google Cloud, PSI is positioned for enhanced operational efficiency and profitability over the next three years. Insights from our recent growth report point to a promising forecast for PSI Software's business outlook. Click here and access our complete balance sheet health report to understand the dynamics of PSI Software. Click here to access our complete index of 181 Undervalued European Stocks Based On Cash Flows. Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks. Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include BIT:REVO OB:BNOR and XTRA:PSAN. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
